FDA Recommends Stronger Yaz Blood Clot Warnings
On December 8, 2011, a Food and Drug Administration (FDA) panel voted in favor of changing the labels for Yaz, Yasmin, and similar birth control pills made with drospirenone, to include stronger warnings about their potential to cause life threatening blood clots. The panel found that the current warnings on those drug labels are insufficient.
A recent FDA-funded study found that those taking drospirenone-based contraceptive bills were 75 percent more likely to experience clots than those who took other oral contraceptive pills. There are more than 10,000 lawsuits claiming that Yaz and Yasmin caused serious blood clots and other harmful side effects. Recently, unsealed court documents revealed that former FDA commissioner David Kessler accused Bayer AG, the maker of Yaz and Yasmin, of hiding evidence of the harmful side effects from the FDA.
If you or someone you know has been harmed by Yaz or Yasmin, contact our office for a free consultation with one of our products liability attorneys.